A patent lawyer with a focus on chemistry, biotechnology, and computer science, Jim Proscia has an extensive technical background that is well-suited to address the multidimensional aspects of modern technology. Jim heads up the Biotechnology practice group and specializes in counseling clients on patent preparation and prosecution, freedom to operate opinions, and portfolio strategizing, particularly in relation to biotechnology, small molecule therapeutics, and other chemical inventions. In addition to his graduate degrees in biotechnology, physics, and chemical physics, Jim spent ten years as a research scientist and technical specialist at Ford Motor Company where he was awarded 14 patents in chemical-related technologies and co-authored several scientific articles. Jim has also been an in-house patent attorney at a pharmaceutical company and an adjunct professor of chemistry at Wayne State University. In the area of computer science, Jim has completed several post graduate courses and has over 20 years of programming experience during which he has designed a number of specialized computer programs that are currently in use. Moreover, Jim's programming experience spans several computer languages, including FORTRAN, C, C#, C++, and Visual Basic. Jim has a particular interest in developing software for bioinformatics. Jim believes that it is mandatory to maintain a current understanding of science and technology in order to be an effective patent attorney. To this end, Jim is an avid science reader and maintains an active role in bioinformatics research. Because of his technical background, Jim believes he can relate well to inventors. His understanding of their work and his ability to speak the same language allows him to draw out the kind of information required to obtain patents with excellence. Publications & Presentations Co-author, Identifying metastatic signatures, including TP53, with a new miRNA-target profiling analysis method, Inhan Lee, Kwanbok Lee, Won-Mean Lee, James W. Proscia, and Yong Sun Lee, Keystone Symposia: MicroRNA and Cancer, February 2011.